{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:24:28Z","timestamp":1792571068237,"version":"4.5.0"},"reference-count":35,"publisher":"American Diabetes Association","issue":"2","license":[{"start":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T00:00:00Z","timestamp":1548028800000},"content-version":"vor","delay-in-days":10,"URL":"http:\/\/www.diabetesjournals.org\/content\/license"}],"funder":[{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"publisher","award":["17\/0005757"],"award-info":[{"award-number":["17\/0005757"]}],"id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01-DK-063829"],"award-info":[{"award-number":["U01-DK-063829"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01-DK-096926"],"award-info":[{"award-number":["R01-DK-096926"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["2T32-DK-00724"],"award-info":[{"award-number":["2T32-DK-00724"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT097835MF"],"award-info":[{"award-number":["WT097835MF"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"crossref","award":["16\/0005529"],"award-info":[{"award-number":["16\/0005529"]}],"id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,2,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>Previously generated genetic risk scores (GRSs) for type 1 diabetes (T1D) have not captured all known information at non-HLA loci or, particularly, at HLA risk loci. We aimed to more completely incorporate HLA alleles, their interactions, and recently discovered non-HLA loci into an improved T1D GRS (termed the \u201cT1D GRS2\u201d) to better discriminate diabetes subtypes and to predict T1D in newborn screening studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                    <jats:p>In 6,481 case and 9,247 control subjects from the Type 1 Diabetes Genetics Consortium, we analyzed variants associated with T1D both in the HLA region and across the genome. We modeled interactions between variants marking strongly associated HLA haplotypes and generated odds ratios to create the improved GRS, the T1D GRS2. We validated our findings in UK Biobank. We assessed the impact of the T1D GRS2 in newborn screening and diabetes classification and sought to provide a framework for comparison with previous scores.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>The T1D GRS2 used 67 single nucleotide polymorphisms (SNPs) and accounted for interactions between 18 HLA DR-DQ haplotype combinations. The T1D GRS2 was highly discriminative for all T1D (area under the curve [AUC] 0.92; P &amp;lt; 0.0001 vs. older scores) and even more discriminative for early-onset T1D (AUC 0.96). In simulated newborn screening, the T1D GRS2 was nearly twice as efficient as HLA genotyping alone and 50% better than current genetic scores in general population T1D prediction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>An improved T1D GRS, the T1D GRS2, is highly useful for classifying adult incident diabetes type and improving newborn screening. Given the cost-effectiveness of SNP genotyping, this approach has great clinical and research potential in T1D.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2337\/dc18-1785","type":"journal-article","created":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T15:14:15Z","timestamp":1547738055000},"page":"200-207","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":382,"title":["Development and Standardization of an Improved Type 1 Diabetes Genetic Risk Score for Use in Newborn Screening and Incident Diagnosis"],"prefix":"10.2337","volume":"42","author":[{"given":"Seth A.","family":"Sharp","sequence":"first","affiliation":[{"name":"Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3872-7793","authenticated-orcid":false,"given":"Stephen S.","family":"Rich","sequence":"additional","affiliation":[{"name":"Center for Public Health Genomics, University of Virginia, Charlottesville, VA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Wood","sequence":"additional","affiliation":[{"name":"Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel E.","family":"Jones","sequence":"additional","affiliation":[{"name":"Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin N.","family":"Beaumont","sequence":"additional","affiliation":[{"name":"Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Harrison","sequence":"additional","affiliation":[{"name":"Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darius A.","family":"Schneider","sequence":"additional","affiliation":[{"name":"Pacific Northwest Diabetes Research Institute, Seattle, WA"},{"name":"Department of Medicine, University of Washington, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9516-5251","authenticated-orcid":false,"given":"Jonathan M.","family":"Locke","sequence":"additional","affiliation":[{"name":"Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jess","family":"Tyrrell","sequence":"additional","affiliation":[{"name":"Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael N.","family":"Weedon","sequence":"additional","affiliation":[{"name":"Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Hagopian","sequence":"additional","affiliation":[{"name":"Pacific Northwest Diabetes Research Institute, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3581-8980","authenticated-orcid":false,"given":"Richard A.","family":"Oram","sequence":"additional","affiliation":[{"name":"Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, U.K."},{"name":"Academic Renal Unit, Royal Devon and Exeter NHS Foundation Trust, Exeter, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2019,1,11]]},"reference":[{"key":"2022031221275648300_B1","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S2213-8587(17)30362-5","article-title":"Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank","volume":"6","author":"Thomas","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2022031221275648300_B2","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1001\/jama.2013.6285","article-title":"Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children","volume":"309","author":"Ziegler","year":"2013","journal-title":"JAMA"},{"key":"2022031221275648300_B3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.molmet.2016.02.003","article-title":"Primary prevention of beta-cell autoimmunity and type 1 diabetes - The Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) perspectives","volume":"5","author":"Ziegler","year":"2016","journal-title":"Mol Metab"},{"key":"2022031221275648300_B4","doi-asserted-by":"crossref","first-page":"e1002548","DOI":"10.1371\/journal.pmed.1002548","article-title":"Genetic scores to stratify risk of developing multiple islet autoantibodies and type 1 diabetes: A prospective study in children","volume":"15","author":"Bonifacio","year":"2018","journal-title":"PLoS Med"},{"key":"2022031221275648300_B5","doi-asserted-by":"crossref","first-page":"330","DOI":"10.2337\/dci15-0029","article-title":"Found in translation: a type 1 diabetes genetic risk score applied to clinical diagnosis","volume":"39","author":"Florez","year":"2016","journal-title":"Diabetes Care"},{"key":"2022031221275648300_B6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1210\/jc.2009-1365","article-title":"Clinical applications of diabetes antibody testing","volume":"95","author":"Bingley","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031221275648300_B7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/08916939908995973","article-title":"Appearance of islet cell autoantibodies after clinical diagnosis of diabetes mellitus","volume":"29","author":"Landin-Olsson","year":"1999","journal-title":"Autoimmunity"},{"key":"2022031221275648300_B8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1464-5491.2011.03419.x","article-title":"Miscoding, misclassification and misdiagnosis of diabetes in primary care","volume":"29","author":"de Lusignan","year":"2012","journal-title":"Diabet Med"},{"key":"2022031221275648300_B9","doi-asserted-by":"crossref","first-page":"e2827","DOI":"10.1136\/bmj.e2827","article-title":"Late onset type 1 diabetes","volume":"344","author":"Lasserson","year":"2012","journal-title":"BMJ"},{"key":"2022031221275648300_B10","doi-asserted-by":"crossref","first-page":"e315","DOI":"10.3399\/bjgp16X684961","article-title":"Practical classification guidelines for diabetes in patients treated with insulin: a cross-sectional study of the accuracy of diabetes diagnosis","volume":"66","author":"Hope","year":"2016","journal-title":"Br J Gen Pract"},{"key":"2022031221275648300_B11","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1056\/NEJMc0805398","article-title":"Concordance for islet autoimmunity among monozygotic twins","volume":"359","author":"Redondo","year":"2008","journal-title":"N Engl J Med"},{"key":"2022031221275648300_B12","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1016\/S0140-6736(16)30582-7","article-title":"Genetic risk factors for type 1 diabetes","volume":"387","author":"Pociot","year":"2016","journal-title":"Lancet"},{"key":"2022031221275648300_B13","doi-asserted-by":"crossref","first-page":"e1000864","DOI":"10.1371\/journal.pgen.1000864","article-title":"The genetic interpretation of area under the ROC curve in genomic profiling","volume":"6","author":"Wray","year":"2010","journal-title":"PLoS Genet"},{"key":"2022031221275648300_B14","doi-asserted-by":"crossref","first-page":"e1000540","DOI":"10.1371\/journal.pgen.1000540","article-title":"Prediction and interaction in complex disease genetics: experience in type 1 diabetes","volume":"5","author":"Clayton","year":"2009","journal-title":"PLoS Genet"},{"key":"2022031221275648300_B15","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1007\/s00125-014-3362-1","article-title":"Feature ranking of type 1 diabetes susceptibility genes improves prediction of type 1 diabetes","volume":"57","author":"Winkler","year":"2014","journal-title":"Diabetologia"},{"key":"2022031221275648300_B16","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2337\/dc15-1111","article-title":"A type 1 diabetes genetic risk score can aid discrimination between type 1 and type 2 diabetes in young adults","volume":"39","author":"Oram","year":"2016","journal-title":"Diabetes Care"},{"key":"2022031221275648300_B17","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.1038\/s41598-018-22574-5","article-title":"Application of a genetic risk score to racially diverse type 1 diabetes populations demonstrates the need for diversity in risk-modeling","volume":"8","author":"Perry","year":"2018","journal-title":"Sci Rep"},{"key":"2022031221275648300_B18","first-page":"1134","article-title":"The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families","volume":"59","author":"Noble","year":"1996","journal-title":"Am J Hum Genet"},{"key":"2022031221275648300_B19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jaut.2015.07.014","article-title":"Immunogenetics of type 1 diabetes: a comprehensive review","volume":"64","author":"Noble","year":"2015","journal-title":"J Autoimmun"},{"key":"2022031221275648300_B20","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.2337\/db07-1331","article-title":"HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families","volume":"57","author":"Erlich","year":"2008","journal-title":"Diabetes"},{"key":"2022031221275648300_B21","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/ng.3353","article-title":"Additive and interaction effects at three amino acid positions in HLA-DQ and HLA-DR molecules drive type 1 diabetes risk","volume":"47","author":"Hu","year":"2015","journal-title":"Nat Genet"},{"key":"2022031221275648300_B22","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/gene.2009.84","article-title":"Overview of the Type I Diabetes Genetics Consortium","volume":"10","author":"Rich","year":"2009","journal-title":"Genes Immun"},{"key":"2022031221275648300_B23"},{"key":"2022031221275648300_B24","doi-asserted-by":"crossref","first-page":"e64683","DOI":"10.1371\/journal.pone.0064683","article-title":"Imputing amino acid polymorphisms in human leukocyte antigens","volume":"8","author":"Jia","year":"2013","journal-title":"PLoS One"},{"key":"2022031221275648300_B25","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/ng.3190","article-title":"Efficient Bayesian mixed-model analysis increases association power in large cohorts","volume":"47","author":"Loh","year":"2015","journal-title":"Nat Genet"},{"key":"2022031221275648300_B26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.7554\/eLife.12089","article-title":"Regulatory polymorphisms modulate the expression of HLA class II molecules and promote autoimmunity","volume":"5","author":"Raj","year":"2016","journal-title":"eLife"},{"key":"2022031221275648300_B27","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1183\/09031936.00033812","article-title":"Genome-wide association analysis reveals 12q13.3-q14.1 as new risk locus for sarcoidosis","volume":"41","author":"Hofmann","year":"2013","journal-title":"Eur Respir J"},{"key":"2022031221275648300_B28","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/ng.3245","article-title":"Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers","volume":"47","author":"Onengut-Gumuscu","year":"2015","journal-title":"Nat Genet"},{"key":"2022031221275648300_B29","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.2337\/db11-0364","article-title":"Genetic analysis of adult-onset autoimmune diabetes","volume":"60","author":"Howson","year":"2011","journal-title":"Diabetes"},{"key":"2022031221275648300_B30","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.2337\/dc18-0087","article-title":"A type 1 diabetes genetic risk score predicts progression of islet autoimmunity and development of type 1 diabetes in individuals at risk","volume":"41","author":"Redondo","year":"2018","journal-title":"Diabetes Care"},{"key":"2022031221275648300_B31","doi-asserted-by":"crossref","first-page":"d4092","DOI":"10.1136\/bmj.d4092","article-title":"Factors associated with the presence of diabetic ketoacidosis at diagnosis of diabetes in children and young adults: a systematic review","volume":"343","author":"Usher-Smith","year":"2011","journal-title":"BMJ"},{"key":"2022031221275648300_B32","doi-asserted-by":"crossref","first-page":"a007732","DOI":"10.1101\/cshperspect.a007732","article-title":"Genetics of type 1 diabetes","volume":"2","author":"Noble","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2022031221275648300_B33","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41588-018-0183-z","article-title":"Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations","volume":"50","author":"Khera","year":"2018","journal-title":"Nat Genet"},{"key":"2022031221275648300_B34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11892-017-0961-5","article-title":"Genetic Risk Scores for Type 1 Diabetes Prediction and Diagnosis","volume":"17","author":"Redondo","year":"2017","journal-title":"Curr Diab Rep"},{"key":"2022031221275648300_B35","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/ng.3968","article-title":"Analysis commons, a team approach to discovery in a big-data environment for genetic epidemiology","volume":"49","author":"Brody","year":"2017","journal-title":"Nat Genet"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/care.diabetesjournals.org\/syndication\/doi\/10.2337\/dc18-1785","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/42\/2\/200\/527296\/dc181785.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/42\/2\/200\/527296\/dc181785.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T18:42:24Z","timestamp":1647110544000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/42\/2\/200\/30342\/Development-and-Standardization-of-an-Improved"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,11]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,1,11]]},"published-print":{"date-parts":[[2019,2,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc18-1785","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,11]]}}}